CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment

Background: Prevention of lung attacks (LAs)/exacerbation is an important treatment goal in both asthma and chronic obstructive pulmonary disease (COPD). However, LAs are often not registered as such in medical records. Objectives: Development and evaluation of CodeX Asthma and COPD. Design: An elec...

Full description

Saved in:
Bibliographic Details
Main Authors: Iris van Geer-Postmus, Marika T. Leving, Yoran H. Gerritsma, Esmé Baan, Lars Dijk, Evelien Harms, David Price, Gerian H. Prins, Jennifer K. Quint, Dermot Ryan, Philippe Salomé, Björn Ställberg, Nilouq Stoker, Janwillem H. Kocks
Format: Article
Language:English
Published: SAGE Publishing 2025-04-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/17534666251329192
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849713214949949440
author Iris van Geer-Postmus
Marika T. Leving
Yoran H. Gerritsma
Esmé Baan
Lars Dijk
Evelien Harms
David Price
Gerian H. Prins
Jennifer K. Quint
Dermot Ryan
Philippe Salomé
Björn Ställberg
Nilouq Stoker
Janwillem H. Kocks
author_facet Iris van Geer-Postmus
Marika T. Leving
Yoran H. Gerritsma
Esmé Baan
Lars Dijk
Evelien Harms
David Price
Gerian H. Prins
Jennifer K. Quint
Dermot Ryan
Philippe Salomé
Björn Ställberg
Nilouq Stoker
Janwillem H. Kocks
author_sort Iris van Geer-Postmus
collection DOAJ
description Background: Prevention of lung attacks (LAs)/exacerbation is an important treatment goal in both asthma and chronic obstructive pulmonary disease (COPD). However, LAs are often not registered as such in medical records. Objectives: Development and evaluation of CodeX Asthma and COPD. Design: An electronic medical record-based algorithm to identify LAs in Dutch primary care patients with asthma or COPD was developed. The algorithms were evaluated in nine general practices in the Netherlands. Results: A total of 479 LAs (in 1164 patients) were identified with CodeX Asthma in the past year, of which only 16% were registered. CodeX COPD identified 321 LAs (in 242 patients) in the past 3 years, of which two were registered. Conclusion: CodeX algorithms are capable of identifying unrecorded LAs and high-risk/uncontrolled patients in an easy way. This offers primary care providers a simple solution to easily identify and closely manage high-risk patients with asthma or COPD by identifying LAs’ frequency and potential under- or overtreatment.
format Article
id doaj-art-4f32169ee5b44a088ba63d454ffd88eb
institution DOAJ
issn 1753-4666
language English
publishDate 2025-04-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Respiratory Disease
spelling doaj-art-4f32169ee5b44a088ba63d454ffd88eb2025-08-20T03:14:01ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46662025-04-011910.1177/17534666251329192CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatmentIris van Geer-PostmusMarika T. LevingYoran H. GerritsmaEsmé BaanLars DijkEvelien HarmsDavid PriceGerian H. PrinsJennifer K. QuintDermot RyanPhilippe SaloméBjörn StällbergNilouq StokerJanwillem H. KocksBackground: Prevention of lung attacks (LAs)/exacerbation is an important treatment goal in both asthma and chronic obstructive pulmonary disease (COPD). However, LAs are often not registered as such in medical records. Objectives: Development and evaluation of CodeX Asthma and COPD. Design: An electronic medical record-based algorithm to identify LAs in Dutch primary care patients with asthma or COPD was developed. The algorithms were evaluated in nine general practices in the Netherlands. Results: A total of 479 LAs (in 1164 patients) were identified with CodeX Asthma in the past year, of which only 16% were registered. CodeX COPD identified 321 LAs (in 242 patients) in the past 3 years, of which two were registered. Conclusion: CodeX algorithms are capable of identifying unrecorded LAs and high-risk/uncontrolled patients in an easy way. This offers primary care providers a simple solution to easily identify and closely manage high-risk patients with asthma or COPD by identifying LAs’ frequency and potential under- or overtreatment.https://doi.org/10.1177/17534666251329192
spellingShingle Iris van Geer-Postmus
Marika T. Leving
Yoran H. Gerritsma
Esmé Baan
Lars Dijk
Evelien Harms
David Price
Gerian H. Prins
Jennifer K. Quint
Dermot Ryan
Philippe Salomé
Björn Ställberg
Nilouq Stoker
Janwillem H. Kocks
CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
Therapeutic Advances in Respiratory Disease
title CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
title_full CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
title_fullStr CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
title_full_unstemmed CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
title_short CodeX effectively identifies high-risk patients with asthma or COPD in Dutch primary care, supporting guideline-driven treatment
title_sort codex effectively identifies high risk patients with asthma or copd in dutch primary care supporting guideline driven treatment
url https://doi.org/10.1177/17534666251329192
work_keys_str_mv AT irisvangeerpostmus codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT marikatleving codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT yoranhgerritsma codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT esmebaan codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT larsdijk codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT evelienharms codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT davidprice codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT gerianhprins codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT jenniferkquint codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT dermotryan codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT philippesalome codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT bjornstallberg codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT nilouqstoker codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment
AT janwillemhkocks codexeffectivelyidentifieshighriskpatientswithasthmaorcopdindutchprimarycaresupportingguidelinedriventreatment